[go: up one dir, main page]

AT249268B - Process for the production of active ingredient preparations for percutaneous administration - Google Patents

Process for the production of active ingredient preparations for percutaneous administration

Info

Publication number
AT249268B
AT249268B AT92864A AT92864A AT249268B AT 249268 B AT249268 B AT 249268B AT 92864 A AT92864 A AT 92864A AT 92864 A AT92864 A AT 92864A AT 249268 B AT249268 B AT 249268B
Authority
AT
Austria
Prior art keywords
production
active ingredient
percutaneous administration
ingredient preparations
preparations
Prior art date
Application number
AT92864A
Other languages
German (de)
Inventor
Friedrich Dr Med Meyer
Original Assignee
Friedrich Dr Med Meyer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Friedrich Dr Med Meyer filed Critical Friedrich Dr Med Meyer
Application granted granted Critical
Publication of AT249268B publication Critical patent/AT249268B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A61K8/315—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92864A 1961-07-20 1962-07-17 Process for the production of active ingredient preparations for percutaneous administration AT249268B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEM49750A DE1227616B (en) 1961-07-20 1961-07-20 Penetration agent

Publications (1)

Publication Number Publication Date
AT249268B true AT249268B (en) 1966-09-12

Family

ID=7306610

Family Applications (2)

Application Number Title Priority Date Filing Date
AT578162A AT258471B (en) 1961-07-20 1962-07-17 Process for the production of active ingredient preparations for percutaneous administration
AT92864A AT249268B (en) 1961-07-20 1962-07-17 Process for the production of active ingredient preparations for percutaneous administration

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT578162A AT258471B (en) 1961-07-20 1962-07-17 Process for the production of active ingredient preparations for percutaneous administration

Country Status (6)

Country Link
AT (2) AT258471B (en)
BR (1) BR6241165D0 (en)
DE (1) DE1227616B (en)
FR (1) FR1329357A (en)
GB (1) GB1001949A (en)
NL (1) NL281225A (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005032A (en) * 1974-09-25 1977-01-25 Xerox Corporation Liquid crystalline composition having mixed cholesteric-nematic properties
FR2308354A1 (en) * 1975-04-22 1976-11-19 Bus Louise Cosmetic lotion for the treatment of acne - contg. benzaldehyde and emollients such as benzoin
IT1066697B (en) * 1976-11-08 1985-03-12 Manetti & Roberts Italo Brit ACTIVATOR FOR COSMETIC COMPOSITIONS AND COSMETIC COMPOSITIONS THAT CONTAIN IT
FR2399834A2 (en) * 1977-08-09 1979-03-09 Bus Louise Skin lotion for treating acne - contains benzaldehyde, softening agent, sodium alginate and tri:ethanolamine
JPS5855411A (en) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd Base material composition and medicinal composition for external use
FR2520233A1 (en) * 1982-01-28 1983-07-29 Oreal COMPOSITION OF ANTHRALIN OR ONE OF ITS DERIVATIVES IN AN AROMATIC ESTER AND ITS USE IN THE TREATMENT OF SKIN DISEASES
JPS58189115A (en) * 1982-04-30 1983-11-04 Kowa Co Drug for external use
JPS5948413A (en) * 1982-09-14 1984-03-19 Grelan Pharmaceut Co Ltd Anti-inflammatory and analgesic agent for external use containing clidanac
AU2314184A (en) * 1983-01-10 1984-07-12 Robert Young & Company Limited Endoparasiticidal composition containing levamisole
JPS6013720A (en) * 1983-07-01 1985-01-24 Nitto Electric Ind Co Ltd Percutaneous administration of physiological activator using adjuvant, solvent and diol modulator
NZ209100A (en) * 1983-08-22 1987-01-23 Ici Australia Ltd Topical compositions for control of endoparasites
US4605670A (en) * 1984-02-01 1986-08-12 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering metoclopramide
FR2566661A1 (en) * 1984-07-02 1986-01-03 Gendler El Method for dissolving griseofulvin for the purpose of preparing a solution of this substance, which is chemically stable and possesses biological activity, for local applications.
US4568343A (en) * 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions
US4865848A (en) * 1987-02-26 1989-09-12 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4906475A (en) 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US4885154A (en) * 1988-03-01 1989-12-05 Alza Corporation Method for reducing sensitization or irritation in transdermal drug delivery and means therefor
JP2905210B2 (en) * 1989-01-23 1999-06-14 フロイント産業株式会社 Transdermal and transmucosal absorption enhancers and transdermal and transmucosal preparations
WO1993007901A1 (en) * 1991-10-26 1993-04-29 Ian Flockhart Composition for topical application
AU2808492A (en) * 1991-10-26 1993-05-21 East Riding Laboratories Limited Medicament composition for topical application
US5900250A (en) 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
WO1993023025A1 (en) * 1992-05-13 1993-11-25 Alza Corporation Transdermal administration of oxybutynin
US5549888A (en) * 1994-01-31 1996-08-27 Procter & Gamble Aqueous topical anti-acne compositions of low pH
US6569661B1 (en) 1999-11-12 2003-05-27 Biomarin Pharmaceutical Inc. Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
US6426208B1 (en) 1999-11-12 2002-07-30 Harbor-Ucla Research And Education Institute Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
US6585971B1 (en) 1999-11-12 2003-07-01 Harbor-Ucla Research And Education Institute Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof
US6866844B2 (en) 2002-11-07 2005-03-15 Biomarin Pharmaceutical Inc. Precursor N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
CN1190190C (en) * 2001-11-23 2005-02-23 王卫 Antiviral and antibacterial cantharidinic anhydride medicine composition and its prepn process
JP2006520374A (en) 2003-03-14 2006-09-07 エピスタム リミテッド Treatment and / or prevention of non-viral epithelial damage
DE102004031210A1 (en) * 2004-06-28 2006-02-09 Trommsdorff Gmbh & Co. Kg MLV cosmetic
GB0915315D0 (en) 2009-09-03 2009-10-07 Univ Manchester Use of non-digestible oligosaccharides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE801283C (en) * 1948-10-02 1950-12-28 Johann Schmid Process for the preparation of a liniment
DE870323C (en) * 1948-10-02 1953-03-12 Johann Schmid Process for the preparation of a liniment

Also Published As

Publication number Publication date
DE1227616B (en) 1966-10-27
GB1001949A (en) 1965-08-18
AT258471B (en) 1967-11-27
BR6241165D0 (en) 1973-06-14
NL281225A (en)
FR1329357A (en) 1963-06-07

Similar Documents

Publication Publication Date Title
AT249268B (en) Process for the production of active ingredient preparations for percutaneous administration
CH441340A (en) Process for the preparation of 3-pyrazolidinone derivatives
CH429724A (en) Process for the preparation of thiaxanthene derivatives
AT239788B (en) Process for the preparation of new β-carboline-carboxamide derivatives
CH434294A (en) Process for the preparation of 1-phenyl-2-aminoethanol derivatives
CH445021A (en) Process for the manufacture of therapeutically active preparations with long lasting effects for oral administration
CH407107A (en) Process for the preparation of dihydrofusidic acid
AT244957B (en) Process for the preparation of new imidazolidine derivatives
AT230894B (en) Process for the preparation of new pyridazine derivatives
CH427815A (en) Process for the preparation of therapeutically active quinolizine derivatives
CH439326A (en) Process for the preparation of phenyl-propylamine derivatives
CH426847A (en) Process for the preparation of new therapeutically active pyrazolone derivatives
CH442352A (en) Process for the preparation of 2-alkoxy-3,4-dihydroxy-5-hydroxymethyl-tetrahydrofuran derivatives
CH401062A (en) Process for the preparation of 8-hydroxy-penillic acid
AT225700B (en) Process for the preparation of phenylalkanolamine derivatives
AT250572B (en) Process for the preparation of new heptapeptide derivatives
AT241473B (en) Process for the preparation of new 1-azathiaxanthene derivatives
CH420144A (en) Process for the preparation of the therapeutically active 16B-methyl-prednisone-21-acetate
CH407975A (en) Process for the preparation of o-phenethylbenzoic acid
CH425804A (en) Process for the preparation of new pharmacologically active pyrazolidones
CH418343A (en) Process for the preparation of 4-oxo-6-sulfamyl-1,2,3,4-tetrahydroquinazolinone derivatives
AT227710B (en) Process for the preparation of new pyridazine derivatives
AT232512B (en) Process for the preparation of amino-dithiohydroquinone derivatives
CH447177A (en) Process for the preparation of 2-dehydroemetine derivatives
CH438290A (en) Process for the preparation of 2a-methylandrostane derivatives